Congleton Jon (CIK 1644975) reported 21 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-30). Recent activity: Sell MLYS (58,000 shares), Sell MLYS (17,000 shares), Sell MLYS (15,730 shares), Sell MLYS (19,364 shares), Sell MLYS (55,183 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-30 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 58,000 | $1.5M |
| 2026-06-30 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 17,000 | $455,896 |
| 2026-04-15 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 15,730 | $421,979 |
| 2026-04-02 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 19,364 | $493,794 |
| 2026-04-02 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 55,183 | $1.5M |
| 2026-04-02 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 453 | $12,254 |
| 2026-02-20 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Buy | 140,900 | $0 |
| 2026-01-13 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 9,119 | $293,723 |
| 2026-01-13 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 7,117 | $235,929 |
| 2025-11-24 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Buy | 24,082 | $13,004 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 12,806 | $533,242 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 8,862 | $374,951 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 4,000 | $174,000 |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 29,207 | $1.3M |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 112,275 | $5.1M |
| 2025-11-13 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 32,850 | $1.5M |
| 2025-10-15 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 13,548 | $577,551 |
| 2025-10-15 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 1,552 | $66,783 |
| 2025-07-15 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 15,884 | $230,477 |
| 2025-04-15 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 15,319 | $186,739 |
| 2025-01-15 | Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer | Sell | 18,333 | $166,097 |
Source: SEC Form 4 filings · as of 2026-06-30